What is Community Pathology?
Community Pathology stands as a prominent provider of pathology services across Middle Tennessee, with specialized expertise spanning breast pathology, cytopathology, molecular diagnostics, dermatopathology, hematopathology, and gastrointestinal pathology. The organization is committed to delivering swift and precise diagnostic services to healthcare providers, thereby facilitating prompt patient treatment. Their team of board-certified pathologists champions a patient-centric methodology, acknowledging the anxieties often associated with medical diagnoses. The company's extensive service portfolio also encompasses women's health diagnostics and general pathology, addressing a broad spectrum of client requirements.
How much funding has Community Pathology raised?
Community Pathology has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Community Pathology
PPP
Public-Private Partnership
What's next for Community Pathology?
The substantial late-stage funding indicates Community Pathology is poised for significant expansion and operational enhancement. This capital injection is likely to fuel advancements in diagnostic technology, service area enlargement, and potentially strategic acquisitions to further solidify its market leadership. The company's focus on specialized subspecialties and a patient-first approach positions it for continued success in the competitive healthcare landscape.
See full Community Pathology company page
